SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-023935
Filing Date
2014-03-31
Accepted
2014-03-31 18:29:26
Documents
1
Period of Report
2014-03-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3951
  Complete submission text file 0001209191-14-023935.txt   5572
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
VERMILLION, INC. (Issuer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address NABI PHARMACEUTICALS 5800 PARK OF COMMERCE BLVD N.W. BOCA RATON FL 33487
Business Address
MCLAIN THOMAS H (Reporting) CIK: 0001206465 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34810 | Film No.: 14731760